Inventor
ANGIBAUD PATRICK RENE
FR80 patents
⚠️ This page may combine multiple inventors who share the name “ANGIBAUD PATRICK RENE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
28 patentsUS7816363B2Oct 19, 2010
Inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV64 citations99
US7615553B2Nov 10, 2009
Inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV61 citations99
US7541369B2Jun 2, 2009
Amino-derivatives as novel inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV54 citations98
US6420387B1Jul 16, 2002
Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivatives
JANSSEN PHARMACEUTICA NV97 citations98
US7767679B2Aug 3, 2010
Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV48 citations97
US6187786B1Feb 13, 2001
Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
JANSSEN PHARMACEUTICA NV119 citations97
US6037350AMar 14, 2000
Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives
JANSSEN PHARMACEUTICA NV112 citations97
US5968952AOct 19, 1999
Farnesyl transferase inhibiting 2-quinolone derivatives
JANSSEN PHARMACEUTICA NV95 citations97
US8343988B2Jan 1, 2013
Inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV24 citations96
US6458800B1Oct 1, 2002
1,2-annelated quinoline derivatives
JANSSEN PHARMACEUTICA NV57 citations95
US7888360B2Feb 15, 2011
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV38 citations92
US7834011B2Nov 16, 2010
Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV39 citations92
US7834025B2Nov 16, 2010
Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV39 citations92
US6914066B2Jul 5, 2005
1,2-annelated quinoline derivatives
JANSSEN PHARMACEUTICA NV21 citations92
US7053105B2May 30, 2006
Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
JANSSEN PHARMACEUTICA NV24 citations91
US7947830B2May 24, 2011
Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV9 citations84
US7943635B2May 17, 2011
Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
JANSSEN PHARMACEUTICA NV7 citations84
US7241777B2Jul 10, 2007
Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
JANSSEN PHARMACEUTICA NV14 citations84
US7196094B2Mar 27, 2007
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
JANSSEN PHARMACEUTICA NV11 citations84
US7173040B2Feb 6, 2007
Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derinazoline derivatives
JANSSEN PHARMACEUTICA NV21 citations84
US7572916B2Aug 11, 2009
Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline
JANSSEN PHARMACEUTICA NV8 citations82
US7524961B2Apr 28, 2009
Diastereoselective addition of lithiated N-methylimidazole on sulfinimines
JANSSEN PHARMACEUTICA NV8 citations82
US7456287B2Nov 25, 2008
Diastereoselective synthesis process for the preparation of imidazole compounds
JANSSEN PHARMACEUTICA NV11 citations82
US9150560B2Oct 6, 2015
Inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV3 citations74
US10611778B2Apr 7, 2020
Fused bicyclic inhibitors of menin-MLL interaction
JANSSEN PHARMACEUTICA NV3 citations71
US7408063B2Aug 5, 2008
1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors
JANSSEN PHARMACEUTICA NV2 citations63
US7129356B2Oct 31, 2006
Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
JANSSEN PHARMACEUTICA NV6 citations63
US9150543B2Oct 6, 2015
Substituted indolyl alkyl amino derivatives as inhibitors of histone deacetylase
JANSSEN PHARMACEUTICA NV2 citations62
ANGIBAUD PATRICK RENE
5 patentsUS8268833B2Sep 18, 2012
Inhibitors of histone deacetylase
ANGIBAUD PATRICK RENE27 citations96
US8404713B2Mar 26, 2013
Quinolinone derivatives as PARP inhibitors
ANGIBAUD PATRICK RENE10 citations83
US8101616B2Jan 24, 2012
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
ANGIBAUD PATRICK RENE9 citations83
US8524711B2Sep 3, 2013
Amino-derivatives as novel inhibitors of histone deacetylase
ANGIBAUD PATRICK RENE4 citations73
US8163765B2Apr 24, 2012
Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
ANGIBAUD PATRICK RENE4 citations62
ASTEX THERAPEUTICS LTD
5 patentsUS9309242B2Apr 12, 2016
Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
ASTEX THERAPEUTICS LTD26 citations94
US9439896B2Sep 13, 2016
Quinolines as FGFR kinase modulators
ASTEX THERAPEUTICS LTD22 citations92
US9309241B2Apr 12, 2016
Naphthyridine derivative compounds
ASTEX THERAPEUTICS LTD26 citations90
US9527844B2Dec 27, 2016
Naphthyridine derivative compounds
ASTEX THERAPEUTICS LTD20 citations89
US10045982B2Aug 14, 2018
Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
ASTEX THERAPEUTICS LTD11 citations84
VERDONCK MARC GUSTAAF CELINE
3 patentsUS8592441B2Nov 26, 2013
Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
VERDONCK MARC GUSTAAF CELINE3 citations72
US8524728B2Sep 3, 2013
Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
VERDONCK MARC GUSTAAF CELINE4 citations72
US8193205B2Jun 5, 2012
Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
VERDONCK MARC GUSTAAF CELINE5 citations72
VENET MARC GASTON
2 patentsJANSSEN PHARMACAEUTIC N V
1 patentJANSSEN CILAG S A
1 patentFREYNE EDDY JEAN EDGARD
1 patentVIALARD JORGE EDUARDO
1 patentJANNSEN CILAG S A
1 patentEMELEN KRISTOF VAN
1 patentMARCONNET-DECRANE LAURENCE FRANCOISE BERNADETTE
1 patentShowing the top 50 of 80 patents by PatentIndex Score.